NIH-funded research P01 program project

Developing new methods to engineer and study viruses in the lab

Official title: Virus, Vector and Cell Culture Core

Funded at University of Pennsylvania · NIH-10914927 · Data updated 2026-11-12

This study is exploring how certain viruses, like Epstein-Barr and Kaposi Sarcoma-associated Herpesvirus, work and how we might use that knowledge to develop better treatments for patients, especially through new gene therapies.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$280,416
NIH project number5P01CA281867-02
Project IDNIH-10914927 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit include individuals affected by diseases related to EBV or KSHV, such as certain lymphomas or other herpesvirus-related conditions.

Less likely to help

Patients with conditions unrelated to EBV or KSHV may not receive any benefit from this research.

What this research studies

This research focuses on creating and manipulating viruses, specifically the Epstein-Barr Virus (EBV) and Kaposi Sarcoma-associated Herpesvirus (KSHV), to better understand their biology and potential treatments. The project involves designing recombinant viruses, producing viral vectors, and establishing 3D organoid cultures to study infections in a controlled environment. Patients may benefit from advancements in gene therapy and targeted treatments that arise from this innovative approach to viral research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies for diseases caused by EBV and KSHV, improving patient outcomes.

How similar studies have gone: Previous research has shown success in using similar viral engineering techniques to develop targeted therapies, indicating a promising avenue for further exploration.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Robertson, Erle S. — University of Pennsylvania
  • Study coordinator: Robertson, Erle S.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.